AK04

N/A

Report date: 2022/11/17 17:33:26

Base Information

Drug NameAK04
Drug Alias NameAK-04
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti Sialic acid-binding Ig-like lectin 6
TargetsSialic acid-binding Ig-like lectin 6
Therapy Area/IndicationsAnaphylaxis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAllakos Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllakos Inc
Inactive CompaniesN/A
Active IndicationsAnaphylaxis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A